Avance Biosciences is pleased to announce that we will be exhibiting at the ASGCT Annual Meeting, taking place this year in Boston. This premier event brings together leaders across the cell and gene therapy field, from academic researchers and clinicians to biotech innovators and regulatory experts, to share the latest scientific and clinical advancements shaping the future of genetic medicine.
Key topics covered during the conference include:
- Cell and gene therapy development and clinical translation
- Gene editing technologies (CRISPR and beyond)
- Viral vector design, manufacturing, and characterization
- Next-generation sequencing (NGS) and genomic analysis
- Immunogenicity and immune response to gene and cell therapies
- Regulatory considerations and evolving guidance for advanced therapies
- Process development, CMC, and product characterization
- Clinical trial design and translational science for genetic medicines
Event Details
- Event: ASGCT (American Society of Gene & Cell Therapy) Annual Meeting
- Dates: May 2026
- Location: Boston, MA – Thomas M. Menino Convention & Exhibition Center (MCEC)
- Avance Booth: #1062
- Exhibit Hours: May 12 – 14 (9:00AM – 6:30PM)
Supporting Cell & Gene Therapy Development
At ASGCT 2026, Avance Biosciences will highlight our comprehensive suite of bioanalytical and CMC testing services tailored for advanced therapies, including:
- Next-Generation Sequencing (NGS) – Genomic characterization, integration site analysis, and detection of off-target effects
- Biodistribution Studies – Quantitative PCR and molecular approaches to assess tissue distribution
- Gene Editing Analysis – CRISPR and other editing platform characterization
- Immunogenicity Testing – ADA and neutralizing antibody assays for viral vectors and biologics
- Molecular and Cell-Based Assays – Supporting identity, purity, potency, and safety assessments
Visit Us at Booth #1062
We invite attendees to stop by Booth #1062 to meet our scientific and business development teams and learn how Avance Biosciences supports cell and gene therapy programs from early development through clinical stages. Our team will be available to discuss project needs, technical challenges, and strategies for generating high-quality, regulatory-ready data.
Advancing Innovation in Genetic Medicine
As the field of cell and gene therapy continues to accelerate, robust analytical strategies are critical for ensuring product safety, efficacy, and consistency. Avance Biosciences partners with sponsors to deliver high-quality data and scientific insight that help de-risk development and streamline regulatory submissions.
Our capabilities are designed to align with evolving regulatory expectations and support IND-enabling and clinical-stage programs.
Planning to attend?
Be sure to visit Booth #1062 and discover how Avance Biosciences can support your next breakthrough in cell and gene therapy.
We look forward to connecting with colleagues, collaborators, and new partners at ASGCT 2026.
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
